Taking together the progressively elevated levels of plasma p‐tau217 alongside increasing MK6240‐SUVR, plasma p‐tau217 may not be confined to its role as a Core 1 biomarker but also serve as a potential biomarker for advanced tau accumulation in AD. The gene discussed is MAPT; the disease is Alzheimer disease.